{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:37:50Z","timestamp":1792175870140,"version":"4.4.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31870987"],"award-info":[{"award-number":["31870987"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.actbio.2021.08.046","type":"journal-article","created":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T23:14:37Z","timestamp":1630710877000},"page":"506-519","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":90,"special_numbering":"C","title":["Mucoadhesive versus mucopenetrating nanoparticles for oral delivery of insulin"],"prefix":"10.1016","volume":"135","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3882-5991","authenticated-orcid":false,"given":"Hongbo","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixiang","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingnan","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirui","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actbio.2021.08.046_bib0001","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.addr.2008.11.002","article-title":"Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues","volume":"61","author":"Lai","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.actbio.2021.08.046_bib0002","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.addr.2018.12.001","article-title":"Strategies for improving diabetic therapy via alternative administration routes that involve stimuli-responsive insulin-delivering systems","volume":"139","author":"Lin","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.actbio.2021.08.046_bib0003","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1021\/acsnano.5b00028","article-title":"Overcoming the diffusion barrier of mucus and absorption barrier of epithelium by self-assembled nanoparticles for oral delivery of insulin","volume":"9","author":"Shan","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.actbio.2021.08.046_bib0004","first-page":"543","article-title":"Modulating intestinal mucus barrier for nanoparticles penetration by surfactants","volume":"14","author":"Zhang","year":"2019","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.actbio.2021.08.046_bib0005","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/17425247.2017.1395853","article-title":"Strategies and industrial perspectives to improve oral absorption of biological macromolecules","volume":"15","author":"Liu","year":"2017","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.actbio.2021.08.046_bib0006","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.addr.2016.03.011","article-title":"How to design the surface of peptide-loaded nanoparticles for efficient oral bioavailability?","volume":"106","author":"Malhaire","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.actbio.2021.08.046_bib0007","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0169-409X(03)00041-3","article-title":"Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications","volume":"55","author":"Vauthier","year":"2003","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.actbio.2021.08.046_bib0008","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1016\/j.progpolymsci.2014.07.010","article-title":"Mucoadhesive polymers in the design of nano-drug delivery systems for administration by non-parenteral routes: a review","volume":"39","author":"Sosnik","year":"2014","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/j.actbio.2021.08.046_bib0009","first-page":"275","article-title":"Developments of mucus penetrating nanoparticles","volume":"10","author":"Liu","year":"2015","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.actbio.2021.08.046_bib0010","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ejpb.2015.11.003","article-title":"Mucoadhesive vs. mucopenetrating particulate drug delivery","volume":"98","author":"Netsomboon","year":"2016","journal-title":"Eur. J. Pharm. Bio."},{"key":"10.1016\/j.actbio.2021.08.046_bib0011","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1039\/C8BM00664D","article-title":"Transient binding promotes molecule penetration into mucin hydrogels by enhancing molecular partitioning","volume":"6","author":"Marczynski","year":"2018","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.actbio.2021.08.046_bib0012","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1021\/ma061865l","article-title":"A route to nonfunctionalized and functionalized poly(n-butylcyanoacrylate) nanoparticles:\u2009 preparation in miniemulsion","volume":"40","author":"Weiss","year":"2007","journal-title":"Macromolecules"},{"key":"10.1016\/j.actbio.2021.08.046_bib0013","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1517\/17425240902870413","article-title":"Poly(alkylcyanoacrylate) nanoparticles for enhanced delivery of therapeutics - is there real potential?","volume":"6","author":"Graf","year":"2009","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.actbio.2021.08.046_bib0014","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.addr.2009.08.004","article-title":"Chitosan-based formulations for delivery of DNA and siRNA","volume":"62","author":"Mao","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.actbio.2021.08.046_bib0015","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jconrel.2017.12.034","article-title":"Design and intestinal mucus penetration mechanism of core-shell nanocomplex","volume":"272","author":"Zhang","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2021.08.046_bib0016","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.jconrel.2020.02.034","article-title":"Design of self-polymerized insulin loaded poly(n-butylcyanoacrylate) nanoparticles for tunable oral delivery","volume":"321","author":"Cheng","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2021.08.046_bib0017","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ijpharm.2018.10.068","article-title":"Enhanced oral insulin delivery via surface hydrophilic modification of chitosan copolymer based self-assembly polyelectrolyte nanocomplex","volume":"554","author":"Liu","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.actbio.2021.08.046_bib0018","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1016\/j.actbio.2014.05.003","article-title":"Uptake, transport and peroral absorption of fatty glyceride grafted chitosan copolymer-enoxaparin nanocomplexes: influence of glyceride chain length","volume":"10","author":"Wang","year":"2014","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2021.08.046_bib0019","doi-asserted-by":"crossref","first-page":"8712","DOI":"10.1016\/j.biomaterials.2011.07.086","article-title":"Effects of chitosan-nanoparticle-mediated tight junction opening on the oral absorption of endotoxins","volume":"32","author":"Sonaje","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2021.08.046_bib0020","doi-asserted-by":"crossref","first-page":"7519","DOI":"10.15376\/biores.13.4.7519-7533","article-title":"Fluorescent sodium alginate applied to papermaking furnish with polyamideamine epichlorohydrin","volume":"13","author":"Ning","year":"2018","journal-title":"Bioresources"},{"key":"10.1016\/j.actbio.2021.08.046_bib0021","doi-asserted-by":"crossref","first-page":"5615","DOI":"10.1038\/ncomms6615","article-title":"Assembling programmable FRET-based photonic networks using designer DNA scaffolds","volume":"5","author":"Buckhout-White","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.actbio.2021.08.046_bib0022","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jconrel.2015.12.008","article-title":"Efficient mucus permeation and tight junction opening by dissociable \"mucus-inert\" agent coated trimethyl chitosan nanoparticles for oral insulin delivery","volume":"222","author":"Liu","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2021.08.046_bib0023","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.addr.2019.04.009","article-title":"Application of f\u00f6rster resonance energy transfer (FRET) technique to elucidate intracellular and in vivo biofate of nanomedicines","volume":"143","author":"Chen","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.actbio.2021.08.046_bib0024","first-page":"94","article-title":"Study on the diabetic model induced by alloxan in wistar rats","volume":"35","author":"Jing","year":"2001","journal-title":"J. Harbin Med. Univ."},{"key":"10.1016\/j.actbio.2021.08.046_bib0025","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jconrel.2017.09.003","article-title":"Potential of insulin nanoparticle formulations for oral delivery and diabetes treatment","volume":"264","author":"Wong","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2021.08.046_bib0026","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ijpharm.2018.05.076","article-title":"Chitosan based polymer-lipid hybrid nanoparticles for oral delivery of enoxaparin","volume":"547","author":"Dong","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.actbio.2021.08.046_bib0027","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s003960050516","article-title":"Formation of positively charged poly(butyl cyanoacrylate) nanoparticles stabilized with chitosan","volume":"278","author":"Yang","year":"2000","journal-title":"Colloid Polym. Sci."},{"key":"10.1016\/j.actbio.2021.08.046_bib0028","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.1016\/j.biomaterials.2003.11.001","article-title":"In vitro degradation of insulin-loaded poly (n-butylcyanoacrylate) nanoparticles","volume":"25","author":"Sullivan","year":"2004","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2021.08.046_bib0029","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.carbpol.2011.03.050","article-title":"Chitosan\u2013glutathione conjugate-coated poly(butyl cyanoacrylate) nanoparticles: promising carriers for oral thymopentin delivery","volume":"86","author":"Jin","year":"2011","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.actbio.2021.08.046_bib0030","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.2174\/1381612825666190425163424","article-title":"Alginate nanoparticles for drug delivery and targeting","volume":"25","author":"Severino","year":"2019","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.actbio.2021.08.046_bib0031","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jconrel.2014.09.031","article-title":"Targeting of gastrointestinal tract for amended delivery of protein\/peptide therapeutics: strategies and industrial perspectives","volume":"196","author":"Pawar","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2021.08.046_bib0032","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/star.201200231","article-title":"Modified starch (cationized)\u2013alginate beads containing aceclofenac: formulation optimization using central composite design","volume":"65","author":"Malakar","year":"2013","journal-title":"Starch St\u00e4rke"},{"key":"10.1016\/j.actbio.2021.08.046_bib0033","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/jps.20520","article-title":"Self-assembled polyelectrolyte nanocomplexes between chitosan derivatives and insulin","volume":"95","author":"Mao","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.actbio.2021.08.046_bib0034","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.addr.2008.09.008","article-title":"Barrier properties of mucus","volume":"61","author":"Cone","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.actbio.2021.08.046_bib0035","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1016\/j.biomaterials.2004.07.050","article-title":"Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs","volume":"26","author":"Yin Win","year":"2005","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2021.08.046_bib0036","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jcis.2019.08.027","article-title":"Alginate-chitosan coated layered double hydroxide nanocomposites for enhanced oral vaccine delivery","volume":"556","author":"Yu","year":"2019","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.actbio.2021.08.046_bib0037","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-015-0156-7","article-title":"Cellular uptake and intracellular degradation of poly(alkyl cyanoacrylate) nanoparticles","volume":"14","author":"Sulheim","year":"2016","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.actbio.2021.08.046_bib0038","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2009.09.004","article-title":"Biodegradation, biodistribution and toxicity of chitosan","volume":"62","author":"Kean","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.actbio.2021.08.046_bib0039","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ejpb.2015.01.022","article-title":"Nano-carrier systems: strategies to overcome the mucus gel barrier","volume":"96","author":"D\u00fcnnhaupt","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.actbio.2021.08.046_bib0040","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.addr.2011.12.009","article-title":"Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers","volume":"64","author":"Ensign","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.actbio.2021.08.046_bib0041","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.addr.2008.11.002","article-title":"Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues","volume":"61","author":"Lai","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.actbio.2021.08.046_bib0042","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/jb\/mvv121","article-title":"Intestinal M cells","volume":"159","author":"Ohno","year":"2016","journal-title":"J. Biochem."},{"key":"10.1016\/j.actbio.2021.08.046_bib0043","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.nano.2014.02.014","article-title":"Intestinal absorption of insulin nanoparticles: contribution of M cells","volume":"10","author":"Lopes","year":"2014","journal-title":"Nanomedicine"},{"key":"10.1016\/j.actbio.2021.08.046_bib0044","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejps.2009.11.002","article-title":"Transport of chitosan-DNA nanoparticles in human intestinal M-cell model versus normal intestinal enterocytes","volume":"39","author":"Kadiyala","year":"2010","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.actbio.2021.08.046_bib0045","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/nrd4608","article-title":"From sewer to saviour - targeting the lymphatic system to promote drug exposure and activity","volume":"14","author":"Trevaskis","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.actbio.2021.08.046_bib0046","doi-asserted-by":"crossref","first-page":"13803","DOI":"10.1073\/pnas.1305882110","article-title":"Unique insights into the intestinal absorption, transit, and subsequent biodistribution of polymer-derived microspheres","volume":"110","author":"Reineke","year":"2013","journal-title":"PNAS"},{"key":"10.1016\/j.actbio.2021.08.046_bib0047","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.addr.2011.07.003","article-title":"Gut-associated lymphoid tissues for the development of oral vaccines","volume":"64","author":"Kunisawa","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.actbio.2021.08.046_bib0048","doi-asserted-by":"crossref","first-page":"17498","DOI":"10.1073\/pnas.1313839110","article-title":"Oral delivery system prolongs blood circulation of docetaxel nanocapsules via lymphatic absorption","volume":"110","author":"Attili-Qadri","year":"2013","journal-title":"PNAS"},{"key":"10.1016\/j.actbio.2021.08.046_bib0049","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1039\/c2cs15344k","article-title":"Targeted polymeric therapeutic nanoparticles: design, development and clinical translation","volume":"41","author":"Kamaly","year":"2012","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.actbio.2021.08.046_bib0050","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.2042-7158.1998.tb06171.x","article-title":"Evaluation of oral mucoadhesive microspheres in man on the basis of the pharmacokinetics of furosemide and riboflavin, compounds with limited gastrointestinal absorption sites","volume":"50","author":"Akiyama","year":"1998","journal-title":"J. Pharm. Pharmacol."}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706121005791?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706121005791?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T17:47:10Z","timestamp":1761673630000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706121005791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":50,"alternative-id":["S1742706121005791"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2021.08.046","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mucoadhesive versus mucopenetrating nanoparticles for oral delivery of insulin","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2021.08.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}